Overview

Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the bioequivalence between 10 mg tablets (test drug) and 10 mg capsules (reference drug) of meloxicam (UHAC 62 XX) after 7-day administration.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim